It is not currently approved for type 2 diabetes in the US, though Lilly has stated its intention to file for that indication during 2026
Wegovy, derived from semaglutide, acts as a GLP-1 receptor agonist, mimicking the GLP-1 hormone to reduce appetite by increasing insulin secretion and signaling feelings of fullness to the brain, he says
The testing is done by both in-house labs as well as third-party labs to confirm all aspects of product quality, including being free of contaminants
As an essential amino acid, lysine is also a direct building block for tissue repair, bone mineralization, and carnitine production for energy metabolism
On the other hand, GLP-1-based therapies can alter gut microbiota composition and diversity, potentially exerting anti-inflammatory effects that influence host metabolism and overall health
A survey of the administration of drugs to young infants